195 related articles for article (PubMed ID: 29670207)
1. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis.
Arruda LCM; Lima-Júnior JR; Clave E; Moraes DA; Douay C; Fournier I; Moins-Teisserenc H; Covas DT; Simões BP; Farge D; Toubert A; Malmegrim KCR; Oliveira MC
Bone Marrow Transplant; 2018 Oct; 53(10):1319-1327. PubMed ID: 29670207
[TBL] [Abstract][Full Text] [Related]
2. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
[TBL] [Abstract][Full Text] [Related]
3. Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.
Farge D; Arruda LC; Brigant F; Clave E; Douay C; Marjanovic Z; Deligny C; Maki G; Gluckman E; Toubert A; Moins-Teisserenc H
J Hematol Oncol; 2017 Jan; 10(1):21. PubMed ID: 28103947
[TBL] [Abstract][Full Text] [Related]
4. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
[TBL] [Abstract][Full Text] [Related]
5. Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis.
Boukouaci W; Lansiaux P; Lambert NC; Picard C; Clave E; Cras A; Marjanovic Z; Farge D; Tamouza R
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806227
[TBL] [Abstract][Full Text] [Related]
6. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients.
Zanin-Silva DC; Santana-Gonçalves M; Kawashima-Vasconcelos MY; Lima-Júnior JR; Dias JBE; Moraes DA; Covas DT; Malmegrim KCR; Ramalho L; Oliveira MC
Arthritis Res Ther; 2022 Apr; 24(1):95. PubMed ID: 35488348
[TBL] [Abstract][Full Text] [Related]
7. Highly proliferative and functional PD-1
Batorov EV; Aristova TA; Pronkina NV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Shevela EY; Ostanin AA; Chernykh ER
Int Immunopharmacol; 2021 Nov; 100():108093. PubMed ID: 34474273
[TBL] [Abstract][Full Text] [Related]
8. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.
Arruda LCM; Malmegrim KCR; Lima-Júnior JR; Clave E; Dias JBE; Moraes DA; Douay C; Fournier I; Moins-Teisserenc H; Alberdi AJ; Covas DT; Simões BP; Lansiaux P; Toubert A; Oliveira MC
Blood Adv; 2018 Jan; 2(2):126-141. PubMed ID: 29365321
[TBL] [Abstract][Full Text] [Related]
9. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.
Pecher AC; Klein R; Koetter I; Wagner M; Vogel W; Wirths S; Lengerke C; Henes JC
Arthritis Res Ther; 2024 Mar; 26(1):75. PubMed ID: 38509633
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.
Arruda LC; Lorenzi JC; Sousa AP; Zanette DL; Palma PV; Panepucci RA; Brum DS; Barreira AA; Covas DT; Simões BP; Silva WA; Oliveira MC; Malmegrim KC
Bone Marrow Transplant; 2015 Mar; 50(3):380-9. PubMed ID: 25486582
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation Improves Functional Outcomes of Systemic Sclerosis Patients.
Costa-Pereira KR; Guimarães AL; Moraes DA; Dias JBE; Garcia JT; de Oliveira-Cardoso EA; Zombrilli A; Leopoldo V; Costa TM; Simões BP; Oliveira MC
J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S131-S138. PubMed ID: 31397762
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
13. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
Arruda LCM; de Azevedo JTC; de Oliveira GLV; Scortegagna GT; Rodrigues ES; Palma PVB; Brum DG; Guerreiro CT; Marques VD; Barreira AA; Covas DT; Simões BP; Voltarelli JC; Oliveira MC; Malmegrim KCR
Clin Immunol; 2016 Aug; 169():47-57. PubMed ID: 27318116
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience.
Henrique-Neto Á; Vasconcelos MYK; Dias JBE; de Moraes DA; Gonçalves MS; Zanin-Silva DC; Zucoloto TG; de Oliveira MFC; Dotoli GM; Weffort LF; Leopoldo VC; Oliveira MC
Adv Rheumatol; 2021 Feb; 61(1):9. PubMed ID: 33549135
[TBL] [Abstract][Full Text] [Related]
15. Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients.
Strunz PP; Froehlich M; Gernert M; Schwaneck EC; Fleischer A; Pecher AC; Tony HP; Henes JC; Schmalzing M
Front Immunol; 2021; 12():723349. PubMed ID: 34539659
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.
Keret S; Henig I; Zuckerman T; Kaly L; Shouval A; Awisat A; Rosner I; Rozenbaum M; Boulman N; Dortort Lazar A; Molad Y; Sabbah F; Naffaa ME; Hardak E; Slobodin G; Rimar D
Rheumatology (Oxford); 2024 May; 63(6):1534-1538. PubMed ID: 37672021
[TBL] [Abstract][Full Text] [Related]
17. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus.
Ye L; Li L; Wan B; Yang M; Hong J; Gu W; Wang W; Ning G
Stem Cell Res Ther; 2017 Apr; 8(1):90. PubMed ID: 28420440
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.
Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ
Front Immunol; 2021; 12():782935. PubMed ID: 35126353
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
20. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
